

Abstract Submission Guidelines
Abstract Closed
Submission Deadline: 5th of September 2024
Abstracts submitted should not exceed 300 words and should be structured as per the following:
- Only original published or not published research works related to Nephrology are accepted. Therefore, case reports and narrative reviews are not accepted.
- Preparation: The abstract should be a brief structured summary of the paper (300 words max.) stating the Title, Background, Objectives, Methods, Results and Conclusions.
- Responsibility: Authors have full responsibility for any statement submitted in the abstract.
- Authors: provided authors and Institutional Affiliations. List first name followed by middle initial (if applicable) then last name. Name of all authors, and then institutional affiliations. Underline the name of the presenting author.
- Disclosure of No Conflict of Authorship: Authors/Co-Authors should realize that abstracts will be published in booklet as submitted.
- Re-submission will not be accepted after the deadline.
- Selection of Abstracts will be based on Scientific Merit only.
- Awards: Abstracts will be evaluated for quality of content and presentation by panel of anonymous judged. The best presentations (Oral and Poster) will be awarded at the end of the conference
- There is no limit on the number of submissions by author.
- Poster Printing: All participants will be informed of detailed poster printing instructions upon acceptance of the abstract.
Abstract Template
- Author name1, Author name2, … (presenter name is bolded and underlined)
- 1Author’s affiliation and full address: 12 point type, centered, italicized
- 2Author’s affiliation and full address: 12 point type, centered, italicized
- Presenter’s e-mail address: 12 point type, centered, italicized
Introduction (or Purpose): This section must include a concise description of the background or rationale for the study, with the specific purposes, questions addressed, and/or hypotheses tested. Lengthy descriptions of rationale are not necessary and not desirable.
Method: The Method section must describe the study design and general procedures including characteristics and numbers of participants and data collection methods. If the study does not involve primary data collection, information should be provided on the methods used to summarize previously reported data (e.g., narrative or systematic review, meta-analysis).
Results: The Results section should summarize findings as they apply directly to the stated purposes of the article. If the project is ongoing and no results are available at the time of submission, please include projected results.
Conclusions: The Conclusions section must state specifically the extent to which the stated purposes of the article have been met or, if the study is ongoing, the potential implications (theoretical and/or clinical) of the findings.